Align Technology, Inc. (NASDAQ:ALGN) Shares Bought by Trust Co. of Vermont

Trust Co. of Vermont increased its stake in Align Technology, Inc. (NASDAQ:ALGN) by 332.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 692 shares of the medical equipment provider’s stock after acquiring an additional 532 shares during the quarter. Trust Co. of Vermont’s holdings in Align Technology were worth $144,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. True Wealth Design LLC lifted its stake in Align Technology by 10,700.0% during the third quarter. True Wealth Design LLC now owns 108 shares of the medical equipment provider’s stock valued at $27,000 after buying an additional 107 shares in the last quarter. University of Texas Texas AM Investment Management Co. purchased a new stake in shares of Align Technology in the 2nd quarter valued at approximately $31,000. Quarry LP grew its position in Align Technology by 53.0% during the 2nd quarter. Quarry LP now owns 127 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 44 shares in the last quarter. Neo Ivy Capital Management acquired a new stake in Align Technology during the 3rd quarter valued at $32,000. Finally, CVA Family Office LLC lifted its holdings in shares of Align Technology by 85.2% in the third quarter. CVA Family Office LLC now owns 150 shares of the medical equipment provider’s stock valued at $38,000 after purchasing an additional 69 shares in the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ALGN has been the topic of several recent analyst reports. Bank of America upped their price target on Align Technology from $200.00 to $206.00 and gave the company an “underperform” rating in a research report on Friday, December 13th. Stifel Nicolaus reduced their price target on shares of Align Technology from $285.00 to $275.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. Evercore ISI lowered their price objective on shares of Align Technology from $270.00 to $250.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Mizuho began coverage on Align Technology in a report on Wednesday, December 4th. They set an “outperform” rating and a $295.00 price target for the company. Finally, Leerink Partnrs raised shares of Align Technology from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 6th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $268.20.

Align Technology Stock Up 2.4 %

NASDAQ ALGN opened at $224.23 on Monday. The firm has a 50-day moving average price of $222.11 and a two-hundred day moving average price of $228.19. Align Technology, Inc. has a 12-month low of $196.09 and a 12-month high of $335.40. The company has a market capitalization of $16.74 billion, a P/E ratio of 38.26, a P/E/G ratio of 4.64 and a beta of 1.67.

Align Technology (NASDAQ:ALGN) last issued its earnings results on Wednesday, October 23rd. The medical equipment provider reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $2.31 by $0.04. The firm had revenue of $977.87 million for the quarter, compared to the consensus estimate of $990.05 million. Align Technology had a return on equity of 13.99% and a net margin of 11.15%. The company’s revenue was up 1.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.62 EPS. Equities analysts expect that Align Technology, Inc. will post 7.44 EPS for the current year.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.